Antiviral properties of humic acids, Klöcking R. and M. Sprossig: Experientia 28: 607.608, 1972.

In vitro studies of the antiviral activity of ammonium humate against herpes simplex virus type 1 and type 2, Thiel, K. D.; Klocking, R.; Schweizer, H.; Sprossig, M. Zentralbl Bakteriol, 1977; Vol. 239; Issue 3; Pages 304-321.

Interaction of humic acids and humicacid-like polymers with herpes simplex virus type 1. Klöcking R, Humanic Substances in the Aquatic and Terrestrial Environment, Berlin 1991, pp. 408 – 412.

INHIBITORY MECHANISM OF SYNTHETIC HUMATES in HIV-1 INFECTION, Schneider, J., R. Weis, C. Manner, B. Kary, A. Werner, B.J. Seubert, and U.N. Riede, International Conference on AIDS, June 6-11 1993; 9:33 (abstract no. WS-A17-2).

The chemically induced inhibition of HIV-1 replication, Laub, R. Laub BioChem Corp., January 1995. www.laubiochem.com.

Antiviral therapy for human immunodeficiency virus infections, E De Clercq, Clin Microbiol Rev. 1995 Apr; 8(2): 200–239

Inhibition of HIV-1 in Cell Culture by Synthetic Humate Analogues Derived from Hydroquinone, Schneider, J., R. Weis, C. Manner, B. Kary, A. Werner, B.J. Seubert, and U.N. Riede, Virology 218: 389-395, 1996.

Acute systemic toxicity studies of natural product and synthetic humates., Laub, R. Laub BioChem Corp, August 1998. www.laubbiochem.com.

The chemically induced inhibition of HSV infection, Laub, R. Laub BioChem Corp., August 1998. www.laubiochem.com.

Evaluation of the Immunostimulatory Properties of Oxyhumic acid, Van Rensburg, C.E.J., G. Joone, J. Dekker, Fatigue 2000: International Conference, 23-24 April 1999, London, UK.

Laub developing humate with anti-HIV, HSV, HPV and other antiviral activity, Laub, R. Biotechnology Information Institute, February 2000. Antiviral Drug and Vaccine Development Information, Vol. 12, No. 2. ISBN 0897-9871.

An In Vitro Investigation of the Antimicrobial Activity of Oxifulvic Acid, Van Rensburg, C.E.J., A. Van Straten, and J. Dekker, Journal of Antimicrobial Chemotherapy 46: 853-4, 2000.

Phase II Clinical Trial of Oral Oxihumate in HIV-infected Patients, Botes, M.E., J. Dekker, and C.E.J. van Rensburg. XIII International AIDS Conference, 9-14 July 2000, Durban, South Africa.

Evaluation of the Immuno-modulatory Properties of Oxihumate, Van Rensburg, C.E.J., XIII International AIDS Conference, 9-14 July 2000, Durban, South Africa.

An In Vitro Investigation of the Anti-inflammatory Properties of Oxihumate, Jooné, G.K., J. Dekker, C.E.J. van Rensburg. 2001. Anti-inflammatory Properties of Oxihumate. 11th International Congress of Immunology, 22-27 July 2001, Stockholm, Sweden.

An In Vitro Investigation of the Anti-HIV Properties of Oxihumate, Van Rensburg, C.E.J., J. Dekker, E. J. Van Rensburg, R. Weiss, J. Schneider. International Immunopharmacology Congress, 20-26 September 2001, Sun City, South Africa.

Topical Application of Oxifulvic Acid Suppresses the Cutaneous Immune Response in Mice, Van Rensburg, Constance E.J., Susan C.K. Malfeld, and Johan Dekker, Drug Development Research 53, no.1: 29-32, 2001.

Medical Drugs from Humus Matter: Focus on Mumie, Shepetkin, I., A. Khlebnikov, and B.S. Kwon, Drug Development Research 57: 150-159, 2002.

Investigation of the Anti-HIV Properties of Oxihumate, Van Rensburg, C.E.J., J. Dekker, R. Weis, T.-L. Smith, E. Janse van Rensburg, J., Schneider, Chemotherapy 48, no.3, 2002.

Phase I Trial with oral Oxihumate in HIV-infected Patients, Botes, M.E., J. Dekker, and C.E.J. van Rensburg, Drug Development Research 56: 34-9, 2002.

Anti-HSV-1 activity of synthetic humic acid-like polymers derived from p-diphenolic starting compounds. Klöcking R., B. Helbig, G. Schotz, M. Schacke, P. Wutzler, Antivir.

Chem. Chemother. 13: 241–249, 2002.

Investigation of the Immunostimulatory Properties of Oxyhumate, Jooné, G.K., J. Dekker, C.E.J. van Rensburg, Zeitschrift für Naturforschung Redaktion 58c: 263-7, 2003.

MEDICAL ASPECTS AND APPLICATIONS OF HUMIC SUBSTANCES, Renate Klocking, Bjorn Helbig, Biopolymers for Medical and Pharmaceutical Applications, 2005, WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim, ISBN: 3-527-31154-8.

MUTI FROM COAL: SCIENCE AND POLITICS OF HUMIC SUBSTANCE RESEARCH IN SOUTH AFRICA, Jo Lorentzen, Human Sciences Research Council, February 2006.

Potassium Humate Inhibits Complement Activation and the Production of Inflammatory Cytokines In Vitro, van Rensburg CEJ, and Naude PJ. Inflammation. 2009; 32(4):270-6.

Clinical Evaluation of Shilajatu Rasayana in patients with HIV Infection, G. D. Gupta, M.D.(Ay.), N. Sujatha, M.D.(Ay.), Ajay Dhanik, M.D.(Ay.), and N. P. Rai, Ayu. 2010 Jan-Mar; 31(1): 28–32.

The Antiinflammatory Properties of Humic Substances: A Mini Review, C.E.J. van Rensburg, Phytotherapy Research,  Volume 29, Issue 6, June 2015, Pages 791–795.